Cargando…

Protective effect of Livactine against CCl(4) and paracetamol induced hepatotoxicity in adult Wistar rats

BACKGROUND: Liver disease has become one of the serious health problems as it is exposed to many kinds of xenobiotics and therapeutic agents. Moreover the rapidly growing morbidity and mortality from liver disease are attributable to the increasing number of chemical compounds and environmental poll...

Descripción completa

Detalles Bibliográficos
Autores principales: Mayuren, Candasamy, Reddy, Vudumula Varun, Priya, Srikakulam Vishnu, Devi, Vallampatla Anusha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3339113/
https://www.ncbi.nlm.nih.gov/pubmed/22558553
http://dx.doi.org/10.4297/najms.2010.2491
_version_ 1782231309142196224
author Mayuren, Candasamy
Reddy, Vudumula Varun
Priya, Srikakulam Vishnu
Devi, Vallampatla Anusha
author_facet Mayuren, Candasamy
Reddy, Vudumula Varun
Priya, Srikakulam Vishnu
Devi, Vallampatla Anusha
author_sort Mayuren, Candasamy
collection PubMed
description BACKGROUND: Liver disease has become one of the serious health problems as it is exposed to many kinds of xenobiotics and therapeutic agents. Moreover the rapidly growing morbidity and mortality from liver disease are attributable to the increasing number of chemical compounds and environmental pollution. Unfortunately, so far, in the modern era of medicine there is no specific treatment to counter the menacing impact of these dreaded diseases. Many polyherbal formulations are used widely to treat these disorders. Livactine is a polyherbal formulation and is claimed to be useful in jaundice and biliary dysfunctions. Most of these formulations do not have standard and approved reports stating their pharmacological action or therapeutic efficacy. Therefore, there is a need for experimental confirmation of the pharmacological effects of this formulation. The rationale behind the selection of carbon tetrachloride is due to its free radical mechanism based liver injury, and paracetamol is consumed widely by the human population and it is also a potential liver hazard. AIM: To evaluate the anti-hepatotoxic activity of Livactine against carbon tetrachloride & paracetamol induced toxicity in rats. MATERIAL AND METHODS: Albino rats of Wistar strain were used to evaluate the hepatoprotective activity of Livactine against carbon tetrachloride & paracetamol induced toxicity. Liver damage was assessed by estimating various biochemical parameters such as serum glutamate oxaloacetate transaminase, serum glutamate pyruvate transaminase, lactate dehydrogenase, alkaline phosphatase, acid phosphatase, total bilirubin, and total protein. The results of the rats treated with Livactine were compared with that of Liv-52. RESULTS: Livactine showed significant dose dependent hepatoprotective effect by reducing elevated serum enzyme levels when compared to that of Liv-52. CONCLUSION: Our findings confirm that the formulation was found to be effective pharmacologically at higher dose against carbon tetrachloride and paracetamol induced hepatotoxic models and were comparable to that of Liv-52. The resultant hepatoprotective activity of Livactine could be due to its free radical scavenging property of the ingredients.
format Online
Article
Text
id pubmed-3339113
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-33391132012-05-03 Protective effect of Livactine against CCl(4) and paracetamol induced hepatotoxicity in adult Wistar rats Mayuren, Candasamy Reddy, Vudumula Varun Priya, Srikakulam Vishnu Devi, Vallampatla Anusha N Am J Med Sci Original Article BACKGROUND: Liver disease has become one of the serious health problems as it is exposed to many kinds of xenobiotics and therapeutic agents. Moreover the rapidly growing morbidity and mortality from liver disease are attributable to the increasing number of chemical compounds and environmental pollution. Unfortunately, so far, in the modern era of medicine there is no specific treatment to counter the menacing impact of these dreaded diseases. Many polyherbal formulations are used widely to treat these disorders. Livactine is a polyherbal formulation and is claimed to be useful in jaundice and biliary dysfunctions. Most of these formulations do not have standard and approved reports stating their pharmacological action or therapeutic efficacy. Therefore, there is a need for experimental confirmation of the pharmacological effects of this formulation. The rationale behind the selection of carbon tetrachloride is due to its free radical mechanism based liver injury, and paracetamol is consumed widely by the human population and it is also a potential liver hazard. AIM: To evaluate the anti-hepatotoxic activity of Livactine against carbon tetrachloride & paracetamol induced toxicity in rats. MATERIAL AND METHODS: Albino rats of Wistar strain were used to evaluate the hepatoprotective activity of Livactine against carbon tetrachloride & paracetamol induced toxicity. Liver damage was assessed by estimating various biochemical parameters such as serum glutamate oxaloacetate transaminase, serum glutamate pyruvate transaminase, lactate dehydrogenase, alkaline phosphatase, acid phosphatase, total bilirubin, and total protein. The results of the rats treated with Livactine were compared with that of Liv-52. RESULTS: Livactine showed significant dose dependent hepatoprotective effect by reducing elevated serum enzyme levels when compared to that of Liv-52. CONCLUSION: Our findings confirm that the formulation was found to be effective pharmacologically at higher dose against carbon tetrachloride and paracetamol induced hepatotoxic models and were comparable to that of Liv-52. The resultant hepatoprotective activity of Livactine could be due to its free radical scavenging property of the ingredients. Medknow Publications & Media Pvt Ltd 2010-10 /pmc/articles/PMC3339113/ /pubmed/22558553 http://dx.doi.org/10.4297/najms.2010.2491 Text en Copyright: © North American Journal of Medical Sciences http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Mayuren, Candasamy
Reddy, Vudumula Varun
Priya, Srikakulam Vishnu
Devi, Vallampatla Anusha
Protective effect of Livactine against CCl(4) and paracetamol induced hepatotoxicity in adult Wistar rats
title Protective effect of Livactine against CCl(4) and paracetamol induced hepatotoxicity in adult Wistar rats
title_full Protective effect of Livactine against CCl(4) and paracetamol induced hepatotoxicity in adult Wistar rats
title_fullStr Protective effect of Livactine against CCl(4) and paracetamol induced hepatotoxicity in adult Wistar rats
title_full_unstemmed Protective effect of Livactine against CCl(4) and paracetamol induced hepatotoxicity in adult Wistar rats
title_short Protective effect of Livactine against CCl(4) and paracetamol induced hepatotoxicity in adult Wistar rats
title_sort protective effect of livactine against ccl(4) and paracetamol induced hepatotoxicity in adult wistar rats
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3339113/
https://www.ncbi.nlm.nih.gov/pubmed/22558553
http://dx.doi.org/10.4297/najms.2010.2491
work_keys_str_mv AT mayurencandasamy protectiveeffectoflivactineagainstccl4andparacetamolinducedhepatotoxicityinadultwistarrats
AT reddyvudumulavarun protectiveeffectoflivactineagainstccl4andparacetamolinducedhepatotoxicityinadultwistarrats
AT priyasrikakulamvishnu protectiveeffectoflivactineagainstccl4andparacetamolinducedhepatotoxicityinadultwistarrats
AT devivallampatlaanusha protectiveeffectoflivactineagainstccl4andparacetamolinducedhepatotoxicityinadultwistarrats